Turkey drew roughly 1.5 million international health patients in 2024 and around $3 billion in related revenue, according to figures published by USHAŞ, the health ministry’s international services arm. Forecasters expect the market to reach $4.6 billion in 2026 and roughly $9.5 billion by 2031, with dentistry and hair transplantation carrying most of the volume.
The more useful question for anyone modelling the sector is who captures that growth, because the composition of Turkish medical tourism is about to change for two reasons that have nothing to do with patient demand.
The arbitrage is narrowing in real terms
The lira passed 46 per dollar in June 2026, a record, and is down roughly 17% over twelve months. That sounds like an ever-widening cost advantage for foreign patients. It isn’t.
Turkish CPI ran at 32.61% in May 2026. The central bank has held its policy rate at 37% and has built its disinflation programme around a policy of real lira appreciation, meaning the currency is not permitted to depreciate faster than monthly inflation. January’s minimum wage rise of 27%, to 28,075 lira, landed below inflation but still repriced a workforce where roughly half of Turkish employees sit at or near that floor.
Run that through a clinic’s P&L. Revenue arrives in sterling or euros. Salaries, rent, utilities and laboratory overhead compound at Turkish inflation. Implant components from Swiss and German manufacturers are invoiced in hard currency, so lira weakness inflates them rather than discounting them. Costs are rising at about 32% while the currency concedes 17%. The gap is a real margin squeeze, and it lands hardest on operators whose only differentiator is a lower number on the quote.
Compliance stopped being optional in 2025
On 26 April 2025 Turkey repealed its 2017 health tourism framework and replaced it with a stricter regime. Healthcare facilities now require an authorisation certificate from the Ministry of Health, applied for through the EKİP platform, while intermediary agencies must obtain one from USHAŞ. Every treatment episode has to be registered on the HealthTürkiye portal, and unregistered episodes are rejected outright for government incentive claims. The 2026 portal participation fee is 120,000 lira.
Complication insurance for surgical and interventional procedures became mandatory as of 31 December 2025. Accreditation from TÜSKA, or the equivalent ministry certification for smaller facilities, is due by 31 December 2026. USHAŞ audits authorised operators at least annually against defined performance criteria, with partial failure triggering a three-month suspension, insufficiency a six-month suspension, and failure at re-evaluation the loss of the certificate.
What the surviving tier already looks like
The clinics positioned to gain share are the ones whose current cost structure is roughly what the 2026 rules will require of everyone.
Component provenance is the clearest marker. Premium implant systems ship with REF and LOT identifiers, and manufacturers including Straumann operate public verification tools that confirm whether a given reference is authentic. One Life Dental, a European-run agency placing patients for dental implants in Turkey, issues those reference codes to patients so authenticity can be checked directly with the manufacturer rather than taken on trust.
Surgical credentials are the second marker. Implant placement performed by oral and maxillofacial surgeons rather than general dentists is a staffing cost, and clinics competing on headline price have an obvious incentive to economise there.
The third is vertical integration and digital workflow. CBCT imaging with digitally guided placement reduces execution variance. In-house milling laboratories reduce exposure to outsourced prosthetic costs, which matters more than usual when domestic input prices are compounding at 32%.
Transparency is the fourth. One Life’s full mouth dental implants Turkey package deals specify the implant brand, the number of implants and crowns, the material, and the length of stay, at a stated price per jaw. Read as an analyst would read it, that is unit-economics disclosure at the patient level.
What to watch
Three data points will tell the story before the revenue figures do. First, how many authorised facilities clear the 31 December 2026 accreditation deadline against the number currently operating. Second, the gap between registered HealthTürkiye treatment episodes and headline health-tourist arrivals, which is a workable proxy for the informal market. Third, whether the central bank sustains real lira appreciation into 2027, since that determines how fast the cost arbitrage keeps closing.
Turkey’s health tourism sector is not slowing down. It is sorting itself, and the sorting mechanism is documentation.
Media ContactCompany Name: One Life DentalContact Person: One Life DentalEmail: Send EmailCountry: TurkeyWebsite: https://oonelifedental.com
